Ending Eclampsia, 2019 This gap analysis not only provides insights into the quality of care women with HDP received postnatally, as well as the outcomes for them and their infants, health statuses, and morbidity patterns, but will improve policy-makers’ and…
Tag Archive for antihypertensive drugs
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial
The Lancet, August 2019 Results showed that alll oral antihypertensives reduced blood pressure to the reference range in most women. As single drugs, nifedipine retard use resulted in a greater frequency of primary outcome attainment than labetalol or methyldopa use.…
Antihypertensive drugs for high blood pressure in pregnancy
Ending Eclampsia, 2019 This brief describes the challenges to ensuring women have access to antihypertensive drugs to control their BP during pregnancy, challenges that include national task shifting policies, frequent stock outs, health worker trainings, and inadequate support for task shifting…
Primary Health Care-Preeclampsia/Eclampsia Plus Model
Ending Eclampsia, 2018 Starting in 2016, Ending Eclampsia initiated six additional implementation research studies in three countries – Bangladesh, Nigeria, Pakistan – to identify and assess additional components that, in conjunction with the Core Model, can further improve prevention, detection,…
Assessing the feasibility and acceptability of community health extension workers to treat hypertension associated with pregnancy: An analysis of post-intervention findings
Ending Eclampsia, 2018 The brief explains research findings on the feasibility and acceptability of community health extension workers treating hypertension in pregnancy and provides recommendations for policy makers and health systems, including supply chains and procurement mechanisms.
Drugs for treating severe hypertension in pregnancy: A network meta-analysis and trial sequential analysis of randomized clinical trials
British Journal of Clinical Pharmacology, 2018 This network meta-analysis suggests similar efficacy nifedipine, hydralazine, and labetalol in the treatment of severe hypertension in pregnancy. The above drugs may also be useful in treating hypertension in severe pre-eclampsia. Moderate quality of evidence was observed for direct comparison…
Nutrition and pre-eclampsia risk factors in Ethiopia
By Khadijah Alibhai In Ethiopia, 412 women die per 100,000 live births. Most of these deaths are preventable, and 19 percent of them are from hypertensive disorders of pregnancy, including pre-eclampsia and eclampsia (PE/E). Typically, pre-eclampsia is detectable during early…
Gaps and opportunities for pre-eclampsia and eclampsia care in Ethiopia
Ending Eclampsia, 2018 This brief provides recommendations for closing gaps in PE/E detection, treatment, and management in Ethiopia at national, health systems, and community levels.
Feasibility of PHC providers prescribing antihypertensive drugs to pregnant women
Ending Eclampsia, 2018 The study will last 12 months and includes 20 to 25 facilities – approximately 50 providers – from two sub-districts, and enrolls 800 pregnant women with hypertension. Researchers anticipate understanding whether it is feasible for PHC providers…
Assessing feasibility and acceptability of CHEWs treating hypertension in pregnancy
Ending Eclampsia, 2018 The research team is measuring outcomes such as proper diagnosis and classification of hypertensive disorders, appropriate use of antihypertensive drugs, effective control of hypertension, use of MgSO4 when necessary, and maternal and fetal outcomes.
